Update on Respect for Human Rights in the Supply Chain
Analysis of human rights issues in corporate supply chains, examining regulatory developments and AEquo’s expectations for responsible practices and transparency.
This year, once again, the climate crisis and energy transition issue was a priority in our dialogues with companies, especially those from the fossil fuel industry and financial
The world is facing an unprecedented biodiversity crisis. In fact, the Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services (IPBES) has highlighted, among other things, the fact that
Issues related to artificial intelligence technologies
The technologies associated with artificial intelligence (AI) have revolutionized all industries, offering companies unprecedented opportunities to improve their efficiency and decision-making. On the other hand, as underscored by
The COVID-19 Crisis: An Opportunity for Pharmaceutical Companies to Demonstrate That They Are Driving Long-term Value Creation by Improving Access to Medicine
Among the ESG issues that we discuss with pharmaceutical companies, access to medicine is an important one. Companies in this sector have a central role to play in